findmyKOL
Clinical trialNCT04263233UnknownObservational

Evaluation of the Optimal Transition Program

SponsorSatellite HealthcareEnrollment20ESRDHemodialysis
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Satellite Healthcare Oakland

    Oakland, California, United States

    Recruiting
  • Satellite Healthcare Sacramento

    Sacramento, California, United States

    Recruiting
  • Satellite Healthcare Chickasaw Gardens

    Memphis, Tennessee, United States

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
29 Jan 2020
Primary completion
28 Jul 2022
Completion
31 Dec 2022
Last update posted
22 Sept 2021
Registered enrollment
20
Registry id
NCT04263233

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.